SCHEMBL10636760

SCHEMBL10636760

CCOC(=O)CCC1NC(=O)CC1c1ccc(OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.46
ALDH1A1 P00352 11/20 0.43
KDM4E B2RXH2 5/20 0.43
HPGD P15428 3/20 0.43
LMNA P02545 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HTT P42858 1/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
TSHR P16473 1/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10642938 0.89 KMT2A (0.41) GAAALDH1A1KDM4EHPGDLMNA
SCHEMBL10637719 0.89 FPR1 (0.42) GAAALDH1A1KDM4ELMNAHSD17B10
SCHEMBL10642253 0.87 HTT (0.44) GAAALDH1A1HPGDLMNAHTT
SCHEMBL10642654 0.87 SMN1; SMN2 (0.47) GAAALDH1A1HTTKMT2AMEN1
SCHEMBL10640610 0.86 HTR2C (0.39) GAAALDH1A1KDM4ECYP2C9CYP2C19
SCHEMBL10641116 0.86 TP53 (0.45) ALDH1A1CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL10641240 0.85 FPR1 (0.40) GAAALDH1A1KDM4EHTTPDE4B
SCHEMBL10642036 0.84 KMT2A (0.41) GAAALDH1A1KDM4ELMNAHSD17B10
SCHEMBL10643991 0.84 GPBAR1 (0.43) ALDH1A1KDM4ELMNAHTTTSHR
SCHEMBL10639201 0.82 SLC6A4 (0.44) GAAALDH1A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0164853-B1 (SUBSTITUTED-PHENYL)-5-OXO-2-PYRROLIDINEPROPANOIC ACIDS, A PROCESS FOR PRODUCING THE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS WARNER-LAMBERT COMPANY (US) 1988-07-06 EP disclosed
US-4584313-A TREATING SENILITY WARNER-LAMBERT COMPANY (US) 1986-04-22 US disclosed